Autologous urethral sling no benefit after prostatectomy

January 19, 2017

(HealthDay)—Placement of a retropubic urethral sling fashioned from autologous vas deferens during robotic assisted radical prostatectomy does not improve recovery of continence, according to a study published in the February issue of The Journal of Urology.

Hao G. Nguyen, M.D., Ph.D., from the University of California-San Francisco, and colleagues conducted a phase 2 trial in which age-stratified patients were randomized to undergo robotic assisted radical prostatectomy by multiple surgeons with or without sling (95 and 100 patients, respectively). The outcomes were complete and near continence at six .

The researchers found that the proportions reporting complete continence were 66 and 65 percent for those without and with a sling, respectively, while 86 and 88 percent, respectively, reported near continence at six months after surgery; times to complete and near continence were similar between the groups. There was a correlation for younger age with higher likelihood of complete and near continence (odds ratios, 1.74 and 2.18 per decreasing five-year interval) after adjustment for clinical, urinary, and surgical factors.

"This trial failed to demonstrate a benefit of autologous urethral sling placement at robotic assisted on early return of continence at six months," the authors write. "Continence was related to patient age in adjusted models."

Explore further: Study confirms difference in radical prostatectomy outcomes between surgeons

More information: Full Text

Related Stories

Rising eye injury rates seen with robotic prostate surgery

October 16, 2012

(HealthDay)—The number of eye injuries associated with robotic-assisted radical prostatectomy—complete removal of the prostate—increased nearly tenfold in the United States between 2000 and 2009, although the risk was ...

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...

Studying a catalyst for blood cancers

April 25, 2017

Imagine this scenario on a highway: A driver starts to make a sudden lane change but realizes his mistake and quickly veers back, too late. Other motorists have already reacted and, in some cases, collide. Meanwhile, the ...

Savior of T-cells may be enemy of liver immune cells

April 24, 2017

Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.